Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Nissay Asset Management Corp Japan ADV

Nissay Asset Management Corp Japan ADV grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 90.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 16,427 shares of the biotechnology company’s stock after acquiring an additional 7,795 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Axon Enterprise were worth $10,037,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. NWI Management LP acquired a new position in Axon Enterprise during the 4th quarter worth $1,426,000. NorthRock Partners LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth $555,000. OMERS ADMINISTRATION Corp raised its stake in shares of Axon Enterprise by 20.5% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 2,987 shares of the biotechnology company’s stock worth $1,775,000 after buying an additional 509 shares in the last quarter. Napa Wealth Management bought a new stake in shares of Axon Enterprise in the 4th quarter worth $267,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Axon Enterprise by 557.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 76,311 shares of the biotechnology company’s stock worth $45,353,000 after buying an additional 64,708 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.5%

Shares of Axon Enterprise stock opened at $728.53 on Thursday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $732.17. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $56.72 billion, a PE ratio of 188.25, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The stock’s fifty day moving average is $576.22 and its 200-day moving average is $589.48.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the company posted $1.15 earnings per share. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. Equities analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Insider Activity

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the business’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,764 shares of company stock worth $14,856,635. 4.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AXON has been the topic of a number of research reports. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research note on Wednesday. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $652.73.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.